Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- CheckyesterdayChange DetectedThe history now notes that recruitment is closed and records a new revision (v3.6.0). The previous revision label (v3.5.5) has been removed.SummaryDifference0.3%

- Check8 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.5' to the study record history and removed the previous entry 'Revision: v3.5.4'. This updates the page's revision history metadata to reflect the latest version.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry (v3.5.4) appears in the Study Record History, superseding the previous v3.5.3. This indicates an update to the record’s metadata rather than substantive changes to the study details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a site UI/version maintenance change rather than an update to the trial record itself.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history log.SummaryDifference0.1%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.